Michael J. Demeure, MD, MBA (Endocrine Surgery)Program Director of Hoag Precision Medicine
In May 2017, Dr. Demeure was named Program Director of Hoag Precision Medicine, a new program focused on tailoring cancer treatment options for each individual patient. The Hoag Family Cancer Institute now utilizes precision medicine through genomic profiling to hone in on the precise molecular abnormalities that create and sustain cancerous tumors. By testing the molecular profile of the tumor cells, doctors can discover what mutations a particular tumor has and tailor a treatment specifically to that mutation. Dr. Demeure, a fellowship-trained endocrine surgeon, has been in academic surgical practice since 1991. As an internationally recognized expert in cancer surgery and research, he has published more than 100 scholarly works.